These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32392564)

  • 41. The evolving management of a rare lymphoproliferative disorder-T-cell prolymphocytic leukemia.
    Gallipoli P; Clark A; Leach M
    Am J Hematol; 2009 Nov; 84(11):750-3. PubMed ID: 19714590
    [No Abstract]   [Full Text] [Related]  

  • 42. Unusually indolent T-cell prolymphocytic leukemia associated with a complex karyotype: is this T-cell chronic lymphocytic leukemia?
    Soma L; Cornfield DB; Prager D; Nowell P; Bagg A
    Am J Hematol; 2002 Nov; 71(3):224-6. PubMed ID: 12410582
    [TBL] [Abstract][Full Text] [Related]  

  • 43. T-cell prolymphocytic leukemia: A rare disease in an elderly female.
    Madaris L
    J Am Acad Nurse Pract; 2010 Dec; 22(12):648-53. PubMed ID: 21129072
    [TBL] [Abstract][Full Text] [Related]  

  • 44. T-cell chronic lymphocytic leukaemia with pulmonary involvement and relapsing BOOP.
    Vaiman E; Odeh M; Attias D; Ben-Arie Y; Oliven A
    Eur Respir J; 1999 Aug; 14(2):471-4. PubMed ID: 10515431
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Case Study Interpretation--Houston: Case 4. T-cell prolymphocytic leukemia.
    Al-Quran SZ
    Cytometry B Clin Cytom; 2011; 80(4):264-8. PubMed ID: 21638771
    [No Abstract]   [Full Text] [Related]  

  • 46. Coronary vasculitis associated with T-cell prolymphocytic leukemia.
    Audemard A; Boutemy J; Guilpain P; Sabatier R; Silva NM; Bienvenu B
    Joint Bone Spine; 2014 Jan; 81(1):93-4. PubMed ID: 23731632
    [No Abstract]   [Full Text] [Related]  

  • 47. Immunophenotypic characterization of T-cell prolymphocytic leukemia.
    Chen X; Cherian S
    Am J Clin Pathol; 2013 Nov; 140(5):727-35. PubMed ID: 24124154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival trends in T cell prolymphocytic leukemia: A SEER database analysis.
    Chandran R; Gardiner SK; Fenske TS; Spurgeon ES
    Leuk Lymphoma; 2016; 57(4):942-4. PubMed ID: 26292711
    [No Abstract]   [Full Text] [Related]  

  • 49. T-cell prolymphocytic leukemia: Review of an entity and its differential diagnostic considerations.
    Frater JL
    Int J Lab Hematol; 2020 Jun; 42 Suppl 1():90-98. PubMed ID: 32543075
    [TBL] [Abstract][Full Text] [Related]  

  • 50. AGO2 in T-prolymphocytic leukemia: its canonical and non-canonical deregulation and function.
    Braun T; Klepzig H; Herling M
    Oncotarget; 2023 May; 14():395-397. PubMed ID: 37141408
    [No Abstract]   [Full Text] [Related]  

  • 51. Inactive T-cell prolymphocytic leukemia with negative surface CD3: Cytogenetic pitfalls.
    Flores-Morán MS; Rodríguez-Sevilla JJ; Arenillas L; Calvo X; Puiggros A; Espinet B; Costan B; Rodríguez-Rivera M; Salido M; Ferrer Del Álamo A
    Int J Lab Hematol; 2023 Jun; 45(3):e55-e59. PubMed ID: 36513944
    [No Abstract]   [Full Text] [Related]  

  • 52. T-cell prolymphocytic leukemia/lymphoma with TCRB::TCL1 translocation.
    Torabi A; Naresh KN
    Blood; 2023 Jul; 142(1):119. PubMed ID: 37410504
    [No Abstract]   [Full Text] [Related]  

  • 53. Diffuse anterior scleritis and secondary glaucoma as a manifestation of adult T-cell prolymphocytic leukemia.
    Kommaraju KR; Moroi S; Demirci H
    Cornea; 2014 Aug; 33(8):873-4. PubMed ID: 24977988
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Idelalisib-Rituximab induces clinical remissions in patients with TP53 disrupted B cell prolymphocytic leukaemia.
    Eyre TA; Fox CP; Shankara P; Went R; Schuh AH
    Br J Haematol; 2017 May; 177(3):486-491. PubMed ID: 27061924
    [No Abstract]   [Full Text] [Related]  

  • 55. Chronic lymphocytic leukemia in a child: a challenging diagnosis in pediatric oncology practice.
    Demir HA; Bayhan T; Üner A; Kurtulan O; Karakuş E; Emir S; Özyörük D; Ceylaner S
    Pediatr Blood Cancer; 2014 May; 61(5):933-5. PubMed ID: 24249660
    [TBL] [Abstract][Full Text] [Related]  

  • 56. T-cell chronic lymphocytic leukemia or small-cell variant of T-cell prolymphocytic leukemia: a historical perspective and search for consensus.
    Rashidi A; Fisher SI
    Eur J Haematol; 2015 Sep; 95(3):199-210. PubMed ID: 25846234
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Primary pulmonary hypertension or portopulmonary hypertension?
    Gossage JR
    Chest; 1998 Oct; 114(4):1224-5. PubMed ID: 9792604
    [No Abstract]   [Full Text] [Related]  

  • 58. [Successful Treatment of T-Cell Prolymphocytic Leukemia with Alemtuzumab].
    Ueki D; Yoshida C; Tsutsumi Oota I; Seki M; Komeno T; Ito H; Ide Y
    Gan To Kagaku Ryoho; 2019 May; 46(5):913-915. PubMed ID: 31189814
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Erythematous eruption with marked conjunctival injection--quiz case. Diagnosis: leukemia cutis with conjunctival involvement in the setting of T-cell prolymphocytic leukemia (T-PLL).
    Kaminska EC; Yu Z; Kress J; Petronic-Rosic V; Soltani K
    Arch Dermatol; 2012 Oct; 148(10):1199. PubMed ID: 23069962
    [No Abstract]   [Full Text] [Related]  

  • 60. A new case of Sézary cell leukemia: a morphological variant of prolymphocytic leukemia.
    Pérez-Vila Mf; Espinet B; Solé F; Pedro C; Woessner S; Florensa L
    Haematologica; 2000 Jul; 85(7):775-6. PubMed ID: 10897140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.